276 related articles for article (PubMed ID: 22980765)
1. Whole-Body muscle MRI in a series of patients with congenital myopathy related to TPM2 gene mutations.
Jarraya M; Quijano-Roy S; Monnier N; Béhin A; Avila-Smirnov D; Romero NB; Allamand V; Richard P; Barois A; May A; Estournet B; Mercuri E; Carlier PG; Carlier RY
Neuromuscul Disord; 2012 Oct; 22 Suppl 2():S137-47. PubMed ID: 22980765
[TBL] [Abstract][Full Text] [Related]
2. Magnetic resonance imaging of muscle in nemaline myopathy.
Jungbluth H; Sewry CA; Counsell S; Allsop J; Chattopadhyay A; Mercuri E; North K; Laing N; Bydder G; Pelin K; Wallgren-Pettersson C; Muntoni F
Neuromuscul Disord; 2004 Dec; 14(12):779-84. PubMed ID: 15564032
[TBL] [Abstract][Full Text] [Related]
3. Whole body muscle MRI protocol: pattern recognition in early onset NM disorders.
Quijano-Roy S; Avila-Smirnow D; Carlier RY;
Neuromuscul Disord; 2012 Oct; 22 Suppl 2():S68-84. PubMed ID: 22980770
[TBL] [Abstract][Full Text] [Related]
4. New morphologic and genetic findings in cap disease associated with beta-tropomyosin (TPM2) mutations.
Ohlsson M; Quijano-Roy S; Darin N; Brochier G; Lacène E; Avila-Smirnow D; Fardeau M; Oldfors A; Tajsharghi H
Neurology; 2008 Dec; 71(23):1896-901. PubMed ID: 19047562
[TBL] [Abstract][Full Text] [Related]
5. Novel TPM3 mutation in a family with cap myopathy and review of the literature.
Schreckenbach T; Schröder JM; Voit T; Abicht A; Neuen-Jacob E; Roos A; Bulst S; Kuhl C; Schulz JB; Weis J; Claeys KG
Neuromuscul Disord; 2014 Feb; 24(2):117-24. PubMed ID: 24239060
[TBL] [Abstract][Full Text] [Related]
6. Muscle MRI in Ullrich congenital muscular dystrophy and Bethlem myopathy.
Mercuri E; Lampe A; Allsop J; Knight R; Pane M; Kinali M; Bonnemann C; Flanigan K; Lapini I; Bushby K; Pepe G; Muntoni F
Neuromuscul Disord; 2005 Apr; 15(4):303-10. PubMed ID: 15792870
[TBL] [Abstract][Full Text] [Related]
7. Congenital myopathy with nemaline rods and cap structures caused by a mutation in the beta-tropomyosin gene (TPM2).
Tajsharghi H; Ohlsson M; Lindberg C; Oldfors A
Arch Neurol; 2007 Sep; 64(9):1334-8. PubMed ID: 17846275
[TBL] [Abstract][Full Text] [Related]
8. Myopathies associated with β-tropomyosin mutations.
Tajsharghi H; Ohlsson M; Palm L; Oldfors A
Neuromuscul Disord; 2012 Nov; 22(11):923-33. PubMed ID: 22749895
[TBL] [Abstract][Full Text] [Related]
9. A novel TPM2 gene splice-site mutation causes severe congenital myopathy with arthrogryposis and dysmorphic features.
Mroczek M; Kabzińska D; Chrzanowska KH; Pronicki M; Kochański A
J Appl Genet; 2017 May; 58(2):199-203. PubMed ID: 27726070
[TBL] [Abstract][Full Text] [Related]
10. Pattern of skeletal muscle involvement in primary dysferlinopathies: a whole-body 3.0-T magnetic resonance imaging study.
Kesper K; Kornblum C; Reimann J; Lutterbey G; Schröder R; Wattjes MP
Acta Neurol Scand; 2009 Aug; 120(2):111-8. PubMed ID: 19154541
[TBL] [Abstract][Full Text] [Related]
11. Frequency and phenotype of patients carrying TPM2 and TPM3 gene mutations in a cohort of 94 patients with congenital myopathy.
Citirak G; Witting N; Duno M; Werlauff U; Petri H; Vissing J
Neuromuscul Disord; 2014 Apr; 24(4):325-30. PubMed ID: 24507666
[TBL] [Abstract][Full Text] [Related]
12. Mutation update and genotype-phenotype correlations of novel and previously described mutations in TPM2 and TPM3 causing congenital myopathies.
Marttila M; Lehtokari VL; Marston S; Nyman TA; Barnerias C; Beggs AH; Bertini E; Ceyhan-Birsoy O; Cintas P; Gerard M; Gilbert-Dussardier B; Hogue JS; Longman C; Eymard B; Frydman M; Kang PB; Klinge L; Kolski H; Lochmüller H; Magy L; Manel V; Mayer M; Mercuri E; North KN; Peudenier-Robert S; Pihko H; Probst FJ; Reisin R; Stewart W; Taratuto AL; de Visser M; Wilichowski E; Winer J; Nowak K; Laing NG; Winder TL; Monnier N; Clarke NF; Pelin K; Grönholm M; Wallgren-Pettersson C
Hum Mutat; 2014 Jul; 35(7):779-90. PubMed ID: 24692096
[TBL] [Abstract][Full Text] [Related]
13. Magnetic resonance imaging of muscle in congenital myopathies associated with RYR1 mutations.
Jungbluth H; Davis MR; Müller C; Counsell S; Allsop J; Chattopadhyay A; Messina S; Mercuri E; Laing NG; Sewry CA; Bydder G; Muntoni F
Neuromuscul Disord; 2004 Dec; 14(12):785-90. PubMed ID: 15564033
[TBL] [Abstract][Full Text] [Related]
14. Absence of beta-tropomyosin is a new cause of Escobar syndrome associated with nemaline myopathy.
Monnier N; Lunardi J; Marty I; Mezin P; Labarre-Vila A; Dieterich K; Jouk PS
Neuromuscul Disord; 2009 Feb; 19(2):118-23. PubMed ID: 19155175
[TBL] [Abstract][Full Text] [Related]
15. Magnetic resonance imaging of skeletal muscles in sporadic inclusion body myositis.
Cox FM; Reijnierse M; van Rijswijk CS; Wintzen AR; Verschuuren JJ; Badrising UA
Rheumatology (Oxford); 2011 Jun; 50(6):1153-61. PubMed ID: 21288962
[TBL] [Abstract][Full Text] [Related]
16. Expanding the clinical, pathological and MRI phenotype of DNM2-related centronuclear myopathy.
Susman RD; Quijano-Roy S; Yang N; Webster R; Clarke NF; Dowling J; Kennerson M; Nicholson G; Biancalana V; Ilkovski B; Flanigan KM; Arbuckle S; Malladi C; Robinson P; Vucic S; Mayer M; Romero NB; Urtizberea JA; García-Bragado F; Guicheney P; Bitoun M; Carlier RY; North KN
Neuromuscul Disord; 2010 Apr; 20(4):229-37. PubMed ID: 20227276
[TBL] [Abstract][Full Text] [Related]
17. Charcot-Marie-Tooth disease type 1A duplication: spectrum of clinical and magnetic resonance imaging features in leg and foot muscles.
Gallardo E; García A; Combarros O; Berciano J
Brain; 2006 Feb; 129(Pt 2):426-37. PubMed ID: 16317020
[TBL] [Abstract][Full Text] [Related]
18. Cap disease due to mutation of the beta-tropomyosin gene (TPM2).
Clarke NF; Domazetovska A; Waddell L; Kornberg A; McLean C; North KN
Neuromuscul Disord; 2009 May; 19(5):348-51. PubMed ID: 19345583
[TBL] [Abstract][Full Text] [Related]
19. MRI in DNM2-related centronuclear myopathy: evidence for highly selective muscle involvement.
Schessl J; Medne L; Hu Y; Zou Y; Brown MJ; Huse JT; Torigian DA; Jungbluth H; Goebel HH; Bönnemann CG
Neuromuscul Disord; 2007 Jan; 17(1):28-32. PubMed ID: 17134899
[TBL] [Abstract][Full Text] [Related]
20. Cap disease caused by heterozygous deletion of the beta-tropomyosin gene TPM2.
Lehtokari VL; Ceuterick-de Groote C; de Jonghe P; Marttila M; Laing NG; Pelin K; Wallgren-Pettersson C
Neuromuscul Disord; 2007 Jun; 17(6):433-42. PubMed ID: 17434307
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
